Lobbying registration dated 2026-01-19
Registrant: RON GERSH
Client: Biovaxys Technology Corp
Targeted institutions:
National Research Council (NRC)
Government funding received:
Lobbying activity details:
BioVaxys is seeking funding support to advance its cancer vaccine development program, including the completion of key studies essential to progressing its clinical pipeline and partnership initiatives.